The Potency Of PLGA-Encapsulated Epigallocatechin Gallate (EGCG) As Adjuvant Therapy For Chronic Kidney Disease

• Main Authors: Deandra Maharani Widiatmaja, Deandra, Alyaa Ulaa Dhiya Ul Haq, Alyaa, Dinda Dwi Purwati, Dinda, Arifa Mustika, Arifa
• Format: Article PeerReviewed
• Language: English; English; Indonesian; English
• Published: World Journal of Advanced Research and Reviews
• Subjects: R5-920 Medicine (General)
• Online Access: https://repository.unair.ac.id/120826/1/13%20artikel.pdf; https://repository.unair.ac.id/120826/2/13%20turnitin.pdf; https://repository.unair.ac.id/120826/3/13%20karil.pdf; https://repository.unair.ac.id/120826/6/13.%20koresponden%20the%20potency%20of.pdf; https://repository.unair.ac.id/120826/; https://wjarr.com/content/potency-plga-encapsulated-epigallocatechin-gallate-egcg-adjuvant-therapy-chronic-kidney; https://doi.org/10.30574/wjarr.2022.13.1.0019
• Institution: Universitas Airlangga

Abstract Chronic kidney disease (CKD) prevalence keeps increasing worldwide and being particular concern due to its morbidity and mortality. However, current CKD therapy are known to be economically costly and not necessarily provide better outcomes. Epigallocatechin gallate (EGCG) is one of the su...